Surgery Combined with LPRF in Denosumab Osteonecrosis of the Jaw: Case Report

Abstract This paper describes two cases in which the use of leucocyte-rich and platelet-rich fibrin (LPRF) combined with bone resection did not result in complete tissue response in the treatment of medication-related osteonecrosis of the jaw (MRONJ). It has been recently described in patients receiving subcutaneous administration of RANK-inhibitors, such as Denosumab, and anti-angiogenic drugs, such as Bevacizumab, as observed in our cases. Due to promising results in recent studies, more patients will receive these medications in order to avoid skeletal complications due to metastatic bone disease and, therefore, this scenario has a potential to become a comparable challenge to the bisphosphonate- induced jaw necrosis in the area of Oral and Maxillofacial Surgery. No convincing surgical technique has been described to overcome the non-healing mucosal lesions with exposed bone due to RANK-inhibitor therapy. Based on the findings in the literature and in both cases described herein can be concluded that the use of LPRF should be considered in the treatment of patients with DRONJ.

Saved in:
Bibliographic Details
Main Authors: Maluf,Gustavo, Pinho,Milena Correia de, Cunha,Sandra Ribeiro de Barros da, Santos,Paulo Sérgio da Silva, Fregnani,Eduardo Rodrigues
Format: Digital revista
Language:English
Published: Fundação Odontológica de Ribeirão Preto 2016
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0103-64402016000300353
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items